Movano (MOVE) Appoints Shaheen Wirk to its Board

Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced the expansion of its board of directors with the addition of Dr. Shaheen Wirk, a leader in healthcare dedicated investment with a track record of success in medicine, partnerships, and research.

With over 20 years of investment experience in public and private life science companies, Dr. Wirk is the founder and Chief Investment Officer of Palkon Capital Management, a healthcare dedicated investment firm launched in partnership with Julian Robertson and Tiger Management. Formerly, Dr. Wirk was a senior analyst at Bridger Capital. He is the founder of the advisory firm Blue Cotinga and was an early employee at MercuryMD, which was successfully acquired by the Thomson Corp. He currently serves on several boards and associations including Tvardi Therapeutics and the Duke University School of Medicine's Medical Alumni Council, the leadership group for the Medical Alumni Association.

"It's an exciting time for Movano in driving healthcare innovation, and they are on the cusp of transforming the delivery of healthcare data," said Dr. Wirk. "The recent FDA approval of the EvieMED Ring allows Movano and its partners to remotely and accurately collect patient-specific key data while enabling more robust clinical development programs and the realization of remote patient monitoring solutions. I am honored to collaborate with Movano to achieve these goals."

Movano Health announced last month that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring. The clearance enables Movano Health to pursue multi-billion dollar business opportunities for health monitoring solutions needed for applications such as clinical trials, post-clinical trial management, and remote patient monitoring for both healthcare providers and payors. The company's first product, the Evie Ring wellness device, is currently in market and sold through www.eviering.com.

"We are at a critical juncture in the evolution of our organization as we continue to innovate at the intersection of consumer wearable and medical device," said John Mastrototaro, President and CEO of Movano Health. "Dr. Wirk is a visionary in the healthcare space and has a wealth of investment experience with both private and public companies and we're excited to have him join the Movano Board of Directors."

Dr. Wirk completed research training programs in oncology and trauma surgery at the University of Texas MD Anderson Cancer Center, Rabin Medical Center through the National Institutes of Health Fogarty International Center, and Duke University Medical Center. Dr. Wirk earned his M.D., M.B.A., and B.S. degrees from Duke University.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Stripe, Advent In Talks To Buy Paypal - WSJ
• Aurora Spine settles patent dispute, secures $600K insider loan